The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global POCT Molecular Diagnostics Market Research Report 2025

Global POCT Molecular Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1735058

No of Pages : 95

Ask Your Query

Synopsis
Highlights
The global POCT Molecular Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for POCT Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for POCT Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of POCT Molecular Diagnostics include Ustar Biotechnologies (Hangzhou) Ltd., Cepheid, Abbott Laboratories, Roche Holding AG, BioFire Diagnostics, Beijing Bohui Innovat Biotech Grp Co Ltd., CapitalBio Corporation, Daan Gene and Sansure Biotech, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for POCT Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POCT Molecular Diagnostics.
The POCT Molecular Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global POCT Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POCT Molecular Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company

  • Ustar Biotechnologies (Hangzhou) Ltd.
  • Cepheid
  • Abbott Laboratories
  • Roche Holding AG
  • BioFire Diagnostics
  • Beijing Bohui Innovat Biotech Grp Co Ltd.
  • CapitalBio Corporation
  • Daan Gene
  • Sansure Biotech
  • Coyote Bioscience Co., Ltd.
  • Genmark Diagnostics, Inc.
  • Mobidiag
  • Wondfo

Segment by Type

  • Molecular Point-of-Care Diagnostics
  • Near-Patient Molecular

Segment by Application

  • Microbiology Laboratory
  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of POCT Molecular Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of POCT Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 POCT Molecular Diagnostics Market Overview
1.1 Product Overview and Scope of POCT Molecular Diagnostics
1.2 POCT Molecular Diagnostics Segment by Type
1.2.1 Global POCT Molecular Diagnostics Market Value Comparison by Type (2023-2029)
1.2.2 Molecular Point-of-Care Diagnostics
1.2.3 Near-Patient Molecular
1.3 POCT Molecular Diagnostics Segment by Application
1.3.1 Global POCT Molecular Diagnostics Market Value by Application: (2023-2029)
1.3.2 Microbiology Laboratory
1.3.3 Hospital
1.3.4 Clinic
1.4 Global POCT Molecular Diagnostics Market Size Estimates and Forecasts
1.4.1 Global POCT Molecular Diagnostics Revenue 2018-2029
1.4.2 Global POCT Molecular Diagnostics Sales 2018-2029
1.4.3 Global POCT Molecular Diagnostics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 POCT Molecular Diagnostics Market Competition by Manufacturers
2.1 Global POCT Molecular Diagnostics Sales Market Share by Manufacturers (2018-2023)
2.2 Global POCT Molecular Diagnostics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global POCT Molecular Diagnostics Average Price by Manufacturers (2018-2023)
2.4 Global POCT Molecular Diagnostics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of POCT Molecular Diagnostics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of POCT Molecular Diagnostics, Product Type & Application
2.7 POCT Molecular Diagnostics Market Competitive Situation and Trends
2.7.1 POCT Molecular Diagnostics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest POCT Molecular Diagnostics Players Market Share by Revenue
2.7.3 Global POCT Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 POCT Molecular Diagnostics Retrospective Market Scenario by Region
3.1 Global POCT Molecular Diagnostics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global POCT Molecular Diagnostics Global POCT Molecular Diagnostics Sales by Region: 2018-2029
3.2.1 Global POCT Molecular Diagnostics Sales by Region: 2018-2023
3.2.2 Global POCT Molecular Diagnostics Sales by Region: 2024-2029
3.3 Global POCT Molecular Diagnostics Global POCT Molecular Diagnostics Revenue by Region: 2018-2029
3.3.1 Global POCT Molecular Diagnostics Revenue by Region: 2018-2023
3.3.2 Global POCT Molecular Diagnostics Revenue by Region: 2024-2029
3.4 North America POCT Molecular Diagnostics Market Facts & Figures by Country
3.4.1 North America POCT Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America POCT Molecular Diagnostics Sales by Country (2018-2029)
3.4.3 North America POCT Molecular Diagnostics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe POCT Molecular Diagnostics Market Facts & Figures by Country
3.5.1 Europe POCT Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe POCT Molecular Diagnostics Sales by Country (2018-2029)
3.5.3 Europe POCT Molecular Diagnostics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific POCT Molecular Diagnostics Market Facts & Figures by Country
3.6.1 Asia Pacific POCT Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific POCT Molecular Diagnostics Sales by Country (2018-2029)
3.6.3 Asia Pacific POCT Molecular Diagnostics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America POCT Molecular Diagnostics Market Facts & Figures by Country
3.7.1 Latin America POCT Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America POCT Molecular Diagnostics Sales by Country (2018-2029)
3.7.3 Latin America POCT Molecular Diagnostics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa POCT Molecular Diagnostics Market Facts & Figures by Country
3.8.1 Middle East and Africa POCT Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa POCT Molecular Diagnostics Sales by Country (2018-2029)
3.8.3 Middle East and Africa POCT Molecular Diagnostics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global POCT Molecular Diagnostics Sales by Type (2018-2029)
4.1.1 Global POCT Molecular Diagnostics Sales by Type (2018-2023)
4.1.2 Global POCT Molecular Diagnostics Sales by Type (2024-2029)
4.1.3 Global POCT Molecular Diagnostics Sales Market Share by Type (2018-2029)
4.2 Global POCT Molecular Diagnostics Revenue by Type (2018-2029)
4.2.1 Global POCT Molecular Diagnostics Revenue by Type (2018-2023)
4.2.2 Global POCT Molecular Diagnostics Revenue by Type (2024-2029)
4.2.3 Global POCT Molecular Diagnostics Revenue Market Share by Type (2018-2029)
4.3 Global POCT Molecular Diagnostics Price by Type (2018-2029)
5 Segment by Application
5.1 Global POCT Molecular Diagnostics Sales by Application (2018-2029)
5.1.1 Global POCT Molecular Diagnostics Sales by Application (2018-2023)
5.1.2 Global POCT Molecular Diagnostics Sales by Application (2024-2029)
5.1.3 Global POCT Molecular Diagnostics Sales Market Share by Application (2018-2029)
5.2 Global POCT Molecular Diagnostics Revenue by Application (2018-2029)
5.2.1 Global POCT Molecular Diagnostics Revenue by Application (2018-2023)
5.2.2 Global POCT Molecular Diagnostics Revenue by Application (2024-2029)
5.2.3 Global POCT Molecular Diagnostics Revenue Market Share by Application (2018-2029)
5.3 Global POCT Molecular Diagnostics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ustar Biotechnologies (Hangzhou) Ltd.
6.1.1 Ustar Biotechnologies (Hangzhou) Ltd. Corporation Information
6.1.2 Ustar Biotechnologies (Hangzhou) Ltd. Description and Business Overview
6.1.3 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolio
6.1.5 Ustar Biotechnologies (Hangzhou) Ltd. Recent Developments/Updates
6.2 Cepheid
6.2.1 Cepheid Corporation Information
6.2.2 Cepheid Description and Business Overview
6.2.3 Cepheid POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cepheid POCT Molecular Diagnostics Product Portfolio
6.2.5 Cepheid Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories POCT Molecular Diagnostics Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Roche Holding AG
6.4.1 Roche Holding AG Corporation Information
6.4.2 Roche Holding AG Description and Business Overview
6.4.3 Roche Holding AG POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roche Holding AG POCT Molecular Diagnostics Product Portfolio
6.4.5 Roche Holding AG Recent Developments/Updates
6.5 BioFire Diagnostics
6.5.1 BioFire Diagnostics Corporation Information
6.5.2 BioFire Diagnostics Description and Business Overview
6.5.3 BioFire Diagnostics POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BioFire Diagnostics POCT Molecular Diagnostics Product Portfolio
6.5.5 BioFire Diagnostics Recent Developments/Updates
6.6 Beijing Bohui Innovat Biotech Grp Co Ltd.
6.6.1 Beijing Bohui Innovat Biotech Grp Co Ltd. Corporation Information
6.6.2 Beijing Bohui Innovat Biotech Grp Co Ltd. Description and Business Overview
6.6.3 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolio
6.6.5 Beijing Bohui Innovat Biotech Grp Co Ltd. Recent Developments/Updates
6.7 CapitalBio Corporation
6.6.1 CapitalBio Corporation Corporation Information
6.6.2 CapitalBio Corporation Description and Business Overview
6.6.3 CapitalBio Corporation POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CapitalBio Corporation POCT Molecular Diagnostics Product Portfolio
6.7.5 CapitalBio Corporation Recent Developments/Updates
6.8 Daan Gene
6.8.1 Daan Gene Corporation Information
6.8.2 Daan Gene Description and Business Overview
6.8.3 Daan Gene POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Daan Gene POCT Molecular Diagnostics Product Portfolio
6.8.5 Daan Gene Recent Developments/Updates
6.9 Sansure Biotech
6.9.1 Sansure Biotech Corporation Information
6.9.2 Sansure Biotech Description and Business Overview
6.9.3 Sansure Biotech POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sansure Biotech POCT Molecular Diagnostics Product Portfolio
6.9.5 Sansure Biotech Recent Developments/Updates
6.10 Coyote Bioscience Co., Ltd.
6.10.1 Coyote Bioscience Co., Ltd. Corporation Information
6.10.2 Coyote Bioscience Co., Ltd. Description and Business Overview
6.10.3 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolio
6.10.5 Coyote Bioscience Co., Ltd. Recent Developments/Updates
6.11 Genmark Diagnostics, Inc.
6.11.1 Genmark Diagnostics, Inc. Corporation Information
6.11.2 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Description and Business Overview
6.11.3 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolio
6.11.5 Genmark Diagnostics, Inc. Recent Developments/Updates
6.12 Mobidiag
6.12.1 Mobidiag Corporation Information
6.12.2 Mobidiag POCT Molecular Diagnostics Description and Business Overview
6.12.3 Mobidiag POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Mobidiag POCT Molecular Diagnostics Product Portfolio
6.12.5 Mobidiag Recent Developments/Updates
6.13 Wondfo
6.13.1 Wondfo Corporation Information
6.13.2 Wondfo POCT Molecular Diagnostics Description and Business Overview
6.13.3 Wondfo POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Wondfo POCT Molecular Diagnostics Product Portfolio
6.13.5 Wondfo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 POCT Molecular Diagnostics Industry Chain Analysis
7.2 POCT Molecular Diagnostics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 POCT Molecular Diagnostics Production Mode & Process
7.4 POCT Molecular Diagnostics Sales and Marketing
7.4.1 POCT Molecular Diagnostics Sales Channels
7.4.2 POCT Molecular Diagnostics Distributors
7.5 POCT Molecular Diagnostics Customers
8 POCT Molecular Diagnostics Market Dynamics
8.1 POCT Molecular Diagnostics Industry Trends
8.2 POCT Molecular Diagnostics Market Drivers
8.3 POCT Molecular Diagnostics Market Challenges
8.4 POCT Molecular Diagnostics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global POCT Molecular Diagnostics Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global POCT Molecular Diagnostics Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global POCT Molecular Diagnostics Market Competitive Situation by Manufacturers in 2022
Table 4. Global POCT Molecular Diagnostics Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global POCT Molecular Diagnostics Sales Market Share by Manufacturers (2018-2023)
Table 6. Global POCT Molecular Diagnostics Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global POCT Molecular Diagnostics Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market POCT Molecular Diagnostics Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of POCT Molecular Diagnostics, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of POCT Molecular Diagnostics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of POCT Molecular Diagnostics, Product Type & Application
Table 12. Global Key Manufacturers of POCT Molecular Diagnostics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global POCT Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POCT Molecular Diagnostics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global POCT Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global POCT Molecular Diagnostics Sales by Region (2018-2023) & (K Units)
Table 18. Global POCT Molecular Diagnostics Sales Market Share by Region (2018-2023)
Table 19. Global POCT Molecular Diagnostics Sales by Region (2024-2029) & (K Units)
Table 20. Global POCT Molecular Diagnostics Sales Market Share by Region (2024-2029)
Table 21. Global POCT Molecular Diagnostics Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global POCT Molecular Diagnostics Revenue Market Share by Region (2018-2023)
Table 23. Global POCT Molecular Diagnostics Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global POCT Molecular Diagnostics Revenue Market Share by Region (2024-2029)
Table 25. North America POCT Molecular Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 27. North America POCT Molecular Diagnostics Sales by Country (2024-2029) & (K Units)
Table 28. North America POCT Molecular Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America POCT Molecular Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe POCT Molecular Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 32. Europe POCT Molecular Diagnostics Sales by Country (2024-2029) & (K Units)
Table 33. Europe POCT Molecular Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe POCT Molecular Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific POCT Molecular Diagnostics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific POCT Molecular Diagnostics Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific POCT Molecular Diagnostics Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific POCT Molecular Diagnostics Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific POCT Molecular Diagnostics Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America POCT Molecular Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 42. Latin America POCT Molecular Diagnostics Sales by Country (2024-2029) & (K Units)
Table 43. Latin America POCT Molecular Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America POCT Molecular Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa POCT Molecular Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa POCT Molecular Diagnostics Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global POCT Molecular Diagnostics Sales (K Units) by Type (2018-2023)
Table 51. Global POCT Molecular Diagnostics Sales (K Units) by Type (2024-2029)
Table 52. Global POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Table 53. Global POCT Molecular Diagnostics Sales Market Share by Type (2024-2029)
Table 54. Global POCT Molecular Diagnostics Revenue (US$ Million) by Type (2018-2023)
Table 55. Global POCT Molecular Diagnostics Revenue (US$ Million) by Type (2024-2029)
Table 56. Global POCT Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 57. Global POCT Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 58. Global POCT Molecular Diagnostics Price (US$/Unit) by Type (2018-2023)
Table 59. Global POCT Molecular Diagnostics Price (US$/Unit) by Type (2024-2029)
Table 60. Global POCT Molecular Diagnostics Sales (K Units) by Application (2018-2023)
Table 61. Global POCT Molecular Diagnostics Sales (K Units) by Application (2024-2029)
Table 62. Global POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Table 63. Global POCT Molecular Diagnostics Sales Market Share by Application (2024-2029)
Table 64. Global POCT Molecular Diagnostics Revenue (US$ Million) by Application (2018-2023)
Table 65. Global POCT Molecular Diagnostics Revenue (US$ Million) by Application (2024-2029)
Table 66. Global POCT Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 67. Global POCT Molecular Diagnostics Revenue Market Share by Application (2024-2029)
Table 68. Global POCT Molecular Diagnostics Price (US$/Unit) by Application (2018-2023)
Table 69. Global POCT Molecular Diagnostics Price (US$/Unit) by Application (2024-2029)
Table 70. Ustar Biotechnologies (Hangzhou) Ltd. Corporation Information
Table 71. Ustar Biotechnologies (Hangzhou) Ltd. Description and Business Overview
Table 72. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product
Table 74. Ustar Biotechnologies (Hangzhou) Ltd. Recent Developments/Updates
Table 75. Cepheid Corporation Information
Table 76. Cepheid Description and Business Overview
Table 77. Cepheid POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Cepheid POCT Molecular Diagnostics Product
Table 79. Cepheid Recent Developments/Updates
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Laboratories POCT Molecular Diagnostics Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. Roche Holding AG Corporation Information
Table 86. Roche Holding AG Description and Business Overview
Table 87. Roche Holding AG POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Roche Holding AG POCT Molecular Diagnostics Product
Table 89. Roche Holding AG Recent Developments/Updates
Table 90. BioFire Diagnostics Corporation Information
Table 91. BioFire Diagnostics Description and Business Overview
Table 92. BioFire Diagnostics POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. BioFire Diagnostics POCT Molecular Diagnostics Product
Table 94. BioFire Diagnostics Recent Developments/Updates
Table 95. Beijing Bohui Innovat Biotech Grp Co Ltd. Corporation Information
Table 96. Beijing Bohui Innovat Biotech Grp Co Ltd. Description and Business Overview
Table 97. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product
Table 99. Beijing Bohui Innovat Biotech Grp Co Ltd. Recent Developments/Updates
Table 100. CapitalBio Corporation Corporation Information
Table 101. CapitalBio Corporation Description and Business Overview
Table 102. CapitalBio Corporation POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CapitalBio Corporation POCT Molecular Diagnostics Product
Table 104. CapitalBio Corporation Recent Developments/Updates
Table 105. Daan Gene Corporation Information
Table 106. Daan Gene Description and Business Overview
Table 107. Daan Gene POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Daan Gene POCT Molecular Diagnostics Product
Table 109. Daan Gene Recent Developments/Updates
Table 110. Sansure Biotech Corporation Information
Table 111. Sansure Biotech Description and Business Overview
Table 112. Sansure Biotech POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Sansure Biotech POCT Molecular Diagnostics Product
Table 114. Sansure Biotech Recent Developments/Updates
Table 115. Coyote Bioscience Co., Ltd. Corporation Information
Table 116. Coyote Bioscience Co., Ltd. Description and Business Overview
Table 117. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product
Table 119. Coyote Bioscience Co., Ltd. Recent Developments/Updates
Table 120. Genmark Diagnostics, Inc. Corporation Information
Table 121. Genmark Diagnostics, Inc. Description and Business Overview
Table 122. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product
Table 124. Genmark Diagnostics, Inc. Recent Developments/Updates
Table 125. Mobidiag Corporation Information
Table 126. Mobidiag Description and Business Overview
Table 127. Mobidiag POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Mobidiag POCT Molecular Diagnostics Product
Table 129. Mobidiag Recent Developments/Updates
Table 130. Wondfo Corporation Information
Table 131. Wondfo Description and Business Overview
Table 132. Wondfo POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Wondfo POCT Molecular Diagnostics Product
Table 134. Wondfo Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. POCT Molecular Diagnostics Distributors List
Table 138. POCT Molecular Diagnostics Customers List
Table 139. POCT Molecular Diagnostics Market Trends
Table 140. POCT Molecular Diagnostics Market Drivers
Table 141. POCT Molecular Diagnostics Market Challenges
Table 142. POCT Molecular Diagnostics Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of POCT Molecular Diagnostics
Figure 2. Global POCT Molecular Diagnostics Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global POCT Molecular Diagnostics Market Share by Type in 2022 & 2029
Figure 4. Molecular Point-of-Care Diagnostics Product Picture
Figure 5. Near-Patient Molecular Product Picture
Figure 6. Global POCT Molecular Diagnostics Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global POCT Molecular Diagnostics Market Share by Application in 2022 & 2029
Figure 8. Microbiology Laboratory
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global POCT Molecular Diagnostics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global POCT Molecular Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 13. Global POCT Molecular Diagnostics Sales (2018-2029) & (K Units)
Figure 14. Global POCT Molecular Diagnostics Average Price (US$/Unit) & (2018-2029)
Figure 15. POCT Molecular Diagnostics Report Years Considered
Figure 16. POCT Molecular Diagnostics Sales Share by Manufacturers in 2022
Figure 17. Global POCT Molecular Diagnostics Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest POCT Molecular Diagnostics Players: Market Share by Revenue in 2022
Figure 19. POCT Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global POCT Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America POCT Molecular Diagnostics Sales Market Share by Country (2018-2029)
Figure 22. North America POCT Molecular Diagnostics Revenue Market Share by Country (2018-2029)
Figure 23. United States POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe POCT Molecular Diagnostics Sales Market Share by Country (2018-2029)
Figure 26. Europe POCT Molecular Diagnostics Revenue Market Share by Country (2018-2029)
Figure 27. Germany POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific POCT Molecular Diagnostics Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific POCT Molecular Diagnostics Revenue Market Share by Region (2018-2029)
Figure 34. China POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America POCT Molecular Diagnostics Sales Market Share by Country (2018-2029)
Figure 44. Latin America POCT Molecular Diagnostics Revenue Market Share by Country (2018-2029)
Figure 45. Mexico POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa POCT Molecular Diagnostics Revenue Market Share by Country (2018-2029)
Figure 50. Turkey POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE POCT Molecular Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of POCT Molecular Diagnostics by Type (2018-2029)
Figure 54. Global Revenue Market Share of POCT Molecular Diagnostics by Type (2018-2029)
Figure 55. Global POCT Molecular Diagnostics Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of POCT Molecular Diagnostics by Application (2018-2029)
Figure 57. Global Revenue Market Share of POCT Molecular Diagnostics by Application (2018-2029)
Figure 58. Global POCT Molecular Diagnostics Price (US$/Unit) by Application (2018-2029)
Figure 59. POCT Molecular Diagnostics Value Chain
Figure 60. POCT Molecular Diagnostics Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock